Profound Medical Corp PROF

$5.84 -0.01 (-0.17%)

Valuation

Market cap
213,888,000
Revenue TTM
$16,100,000
Net income TTM
$-42,570,000
PE ratio
0.00
Forward PE
—
Profit margin
-264.41%
Debt to equity
0.09

Trading

Volume
67,800
Avg volume
131,724
Day's range
$5.79 – $6.00
Shares out
36,562,000
Stochastic %K
41%
Beta
0.75
Analysts
Strong Sell
Price target
$11.12

Price

Company profile

Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate...

Show more

Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.

Industry
Medical Devices
Sector
Healthcare
Phone
647 476 1350
Website
https://www.profoundmedical.com
Address
2400 Skymark Avenue, Unit 6, Mississauga, Canada

Latest news

Stocktwits

johntarlick Sep 23, 9:48 AM
$PROF crikey, driver is out too? that guy has been around for some years in engineering management, much longer than vertuccio, and i think he made it to vp of product development or something. How in the heck does someone with that track record bail now?
1 replies
Yingtrader7 Sep 19, 1:50 PM
$NSYS couple of peers i came across, $TMCI | $PROF fwiw
0 replies
johntarlick Sep 18, 1:58 PM
$PROF crikey, vertuccio is out too? she was hand-picked by the CCO to lead the marketing as he rebuilt the scorched earth from the ground up, and amongst other things she lead the initiative to get the nfl guy as a spokesperson for the brand. how does she pack up and leave just a year later?
1 replies
BioTuesdays Sep 17, 7:15 PM
According to a filing with SEDI, $PROF president, Richard Fabian, acquired a total of 10,000 shares of Profound on the open market today at a cost of $59,800 (U.S.). https://biotuesdays.com/2026/09/17/profound-medicals-new-president-makes-open-market-purchase-of-company-shares/
0 replies
BioTuesdays Sep 11, 1:52 PM
$PROF Titan Partners initiated coverage of Profound Medical with a “buy” rating and price target of $12.00. The stock closed at $5.96 on Sept 10. https://biotuesdays.com/2026/09/11/titan-starts-profound-medical-at-buy-pt-12/
0 replies
focafoca99 Sep 3, 12:55 PM
$PROF management will participate in Lake Street's BIG10 Conference on Sept. 10 in New York City.
1 replies
johntarlick Sep 2, 12:48 PM
$PROF holy cow burtnyk is out as president and COO. and i thought he was on track to succeed CEO menawat in the medium term. a big miss for me, and what the heck is going on in the c-suite anyway? This company is on the cusp of going unicorn (their claim not mine), and three senior leaders are forced out in past 18 months?
1 replies
BioTuesdays Sep 1, 4:24 PM
$PROF has appointed Richard Fabian as president, effective immediately, succeeding Mathieu Burtnyk, PhD, who has assumed the newly created position of chief technology officer. https://biotuesdays.com/2026/09/01/profound-strengthens-leadership-team-with-appointment-of-richard-fabian-as-president/
0 replies